Printer Friendly
The Free Library
14,735,889 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Takeda Pharmaceutical Transfers All BASF Takeda Vitamin Shares to BASF Japan.


Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Jan 6, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Takeda Takeda (武田氏 Takeda)  Pharmaceutical announced on January 5 that it has transferred all of its shares of BASF BASF Bar Association of San Francisco (since 1872; San Francisco, California)
BASF Badische Anilin und Soda Fabrik (German chemical products company)
BASF Builders Association of South Florida
 Takeda Vitamin to BASF Japan as of January 4.

BASF Takeda Vitamin, which was co-established by Takeda Pharmaceutical and BASF Japan in January 2001, is a leading supplier of vitamins and pharmaceutical additives in Japan.

The share transfer was based on the joint venture agreement concluded between the two companies.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jan 7, 2006
Words:82
Previous Article:Shiseido Finds That Some Fragrances Have Greater Effect on Taste When Frequently Experienced.
Next Article:Sony Prototypes 82-inch LCD TV Supporting New Video Color Space Standard xvYCC.



Related Articles
BASF. (Business Briefs: Acquisitions, Expansions) (Brief Article)
Takeda Pharmaceutical and House Foods Form Business Alliance.
Takeda Starts Phase 2 Clinical Studies of ATL-962, an Obesity and Related Disease Treatment, in Japan.
Takeda Pharmaceutical, Affymax Conclude Licensing Agreement for Hematide, Renal/Malignant Anemia Treatment Agent.
House Foods, Takeda Pharmaceutical Conclude Joint Venture Agreement on Beverage and Food Businesses.
Takeda Pharmaceutical to Establish New Sales and Marketing Company in London.
Takeda Announces Start of Phase 3 Clinical Program in the U.S.of Fixed Dose Combination Product of Actos(R) + TAK-536for Treatment of Patients with...
London Symphony Orchestra and Takeda Pharmaceutical Company Launch the 7th Takeda Global Concert Series.
Takeda to Sponsor The LaSalle Bank Chicago Marathon.
Takeda Announces Positive Opinion from European Regulatory Authorities for Combination Use of Actos(R) with Insulin for Type 2 Diabetes.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles